Add Company
Join Now

Bolden Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bolden Therapeutics's estimated annual revenue is currently $387.5k per year.(i)
  • Bolden Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Bolden Therapeutics has 5 Employees.(i)
  • Bolden Therapeutics grew their employee count by -44% last year.

Bolden Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Director ResearchReveal Email/Phone
3
Research Co-OpReveal Email/Phone
4
Executive ChairmanReveal Email/Phone
5
Associate ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M16-20%N/AN/A
#2
$0.3M2-60%N/AN/A
#3
$2.8M6848%$59MN/A
#4
$0.9M60%N/AN/A
#5
$1.1M740%N/AN/A
#6
$1.1M717%N/AN/A
#7
$0.4M5-44%N/AN/A
#8
$0.3M2-71%N/AN/A
#9
$1.9M120%N/AN/A
#10
$19.1M12331%N/AN/A
Add Company

What Is Bolden Therapeutics?

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$387.5k

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M50%N/A
#2
$0.5M717%N/A
#3
$0.5M7-22%N/A
#4
$0.8M7250%N/A
#5
$0.5M8-11%N/A